US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
WDC
$415.29
▲+0.00%
TSLA
$370.59
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
WDC
$415.29
▲+0.00%
TSLA
$370.59
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Jupiter Wellness, Inc. - Common Stock
(NQ:
JUPW
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 14, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jupiter Wellness, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
TLRY is Making waves with this NASDAQ; JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial (NASDAQ: JUPW) Jupiter Wellness
November 16, 2021
Via
Get News
Jupiter Wellness Announces JW-300 Clinical Trial Results
November 16, 2021
JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial. JUPITER, FL / ACCESSWIRE / November 16, 2021 / Jupiter Wellness, Inc....
From
Jupiter Wellness, Inc.
Via
AccessWire
NASDAQ Company Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema (NASDAQ: JUPW) Jupiter Wellness
November 11, 2021
Via
Get News
Jupiter Wellness Completes Pre-IND meeting with the U.S. Food & Drug Administration for JW-100 in the Treatment of Eczema
November 11, 2021
JUPITER, FL / ACCESSWIRE / November 11, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing cannabinoid receptor agonists for the treatment of eczema, actinic keratosis,...
From
Jupiter Wellness, Inc.
Via
AccessWire
Big update for NASDAQ Biotech Jupiter Wellness: NASDAQ: JUPW Applies for IND number from the US Food & Drug Administration
August 16, 2021
Via
Viz Release
NASDAQ Company Completes Pre-IND meeting with the U.S. Food and Drug Administration for JW-100 in the Treatment of Eczema (NASDAQ: JUPW) Jupiter Wellness
November 11, 2021
Via
Viz Release
SPAC Targeting AI Medical Therapeutics and Diagnostics; (NASDAQ: JUPW) Jupiter Wellness Sponsors Jupiter Wellness Acquisition
November 03, 2021
Via
Get News
Topics
Artificial Intelligence
Jupiter Wellness Sponsors Jupiter Wellness Acquisition Corp SPAC Targeting AI Medical Therapeutics and Diagnostics
November 03, 2021
AI in medicine is projected to grow 18X from 2018 through 2025 to $35 billion JUPITER, FL / ACCESSWIRE / November 3, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced that it has filed a...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Artificial Intelligence
SPAC Targeting AI Medical Therapeutics and Diagnostics; (NASDAQ: JUPW) Jupiter Wellness Sponsors Jupiter Wellness Acquisition. AI in medicine is projected to grow 18X from 2018 through 2025 to $35 billion
November 03, 2021
Via
Viz Release
Topics
Artificial Intelligence
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW)
October 19, 2021
Via
Get News
Jupiter Wellness Announces First Patient Dosing for Double-Blinded Placebo Controlled Trial of JW-300 for the Treatment of First Degree Burns
October 19, 2021
JUPITER, FL / ACCESSWIRE / October 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a clinical stage company developing a cannabinoid receptor agonist for the treatment of first degree burns, announced...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Intellectual Property
NASDAQ Company Announces 1st Patient Dosing for Placebo Controlled Trial of JW-300. Treatment of First Degree Burns: Jupiter Wellness, Inc. (NASDAQ: JUPW)
October 19, 2021
Via
Viz Release
4 Penny Stocks Insiders Are Buying
↗
October 08, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
Via
Benzinga
NASDAQ Company in the Multi-Billion Dollar Market Treating Skin Disorders Including Skin Cancer: Jupiter Wellness, Inc. (NASDAQ: JUPW)
October 07, 2021
Via
Get News
Jupiter Wellness Provides Shareholder Update on Multiple Clinical & Commercial Milestones
October 07, 2021
JUPITER, FL / ACCESSWIRE / October 7, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today provided an update on its advancing clinical programs and commercial progress. Commercial: Photocil™ to Launch...
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness Announces Multi-Year Extension of Endorsement Agreement with Pro Golfer Ernie Els
September 08, 2021
Pro Golf Hall of Fame Legend Extends Endorsement of CaniSun Suncare Products JUPITER, FL / ACCESSWIRE / September 8, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of enhanced skin care...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Intellectual Property
Biotech Requests Pre-IND Meeting with the US FDA: Jupiter Wellness: NASDAQ: JUPW JW-100 Clinical Program Treatment for Mild to Moderate Eczema
August 23, 2021
Via
Get News
Jupiter Wellness Submitted a Pre-IND Meeting Request with the US FDA for its Proposed Clinical Program of JW-100 as a Treatment for Mild to Moderate Eczema
August 23, 2021
Following receipt of a Pre-Assignment number from the FDA Jupiter Wellness requests Pre-IND meeting JUPITER, FL / ACCESSWIRE / August 23, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a developer of...
From
Jupiter Wellness, Inc.
Via
AccessWire
Biotech Requests Pre-IND Meeting with the US FDA: Jupiter Wellness: NASDAQ: JUPW JW-100 Clinical Program Treatment for Mild to Moderate Eczema
August 23, 2021
Via
Viz Release
Big update for NASDAQ Biotech Jupiter Wellness: NASDAQ: JUPW Applies for IND number from the US Food & Drug Administration
August 16, 2021
Via
Get News
Stocks That Hit 52-Week Lows On Monday
↗
August 16, 2021
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was Koninklijke Philips (NYSE...
Via
Benzinga
Jupiter Wellness Applies for IND number from the US Food and Drug Administration
August 16, 2021
Following positive results from the JW-100 investigator initiated trials for Eczema, Jupiter Wellness to commence US FDA program JUPITER, FL / ACCESSWIRE / August 16, 2021 / Jupiter Wellness, Inc....
From
Jupiter Wellness, Inc.
Via
AccessWire
Stocks That Hit 52-Week Lows On Tuesday
↗
August 03, 2021
On Tuesday morning, 69 companies achieved new lows for the year. Intriguing Points: Las Vegas Sands (NYSE:LVS) was the largest firm by market cap to set a new 52-...
Via
Benzinga
Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW).
July 26, 2021
NEW YORK, NY / ACCESSWIRE / July 26, 2021 / Aegis Capital Corp. acted as Sole Bookrunner on a $32.5 Million Follow-On Offering of Common Stock and Warrants for Jupiter Wellness, Inc. (NASDAQ:JUPW)....
From
Aegis Capital Corp.
Via
AccessWire
Topics
Retirement
Jupiter Wellness Closes $32.5 Million Underwritten Public Offering of Common Stock and Warrants
July 26, 2021
JUPITER, FL / ACCESSWIRE / July 26, 2021 / Jupiter Wellness, Inc. (the "Company") (NASDAQ:JUPW), today announced the closing of an underwritten public offering (the "Offering") of 11,066,258 shares...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Mid-Afternoon Market Update: Dow Rises Over 50 Points; ImmunoPrecise Antibodies Shares Spike Higher
↗
July 22, 2021
Toward the end of trading Thursday, the Dow traded up 0.16% to 34,853.89 while the NASDAQ rose 0.38% to 14,687.85. The S&P also rose, gaining 0.20% to 4,367.55. The U.S. has...
Via
Benzinga
Topics
Stocks
61 Biggest Movers From Yesterday
↗
July 23, 2021
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares jumped 138.2% to close at $13.22 on Thursday after the company announced new results from its TATX-03 PolyTope Therapy...
Via
Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
↗
July 22, 2021
Gainers ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) shares climbed 129.7% to $12.75 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating...
Via
Benzinga
Mid-Day Market Update: Crude Oil Up 1.5%; Seres Therapeutics Shares Plunge
↗
July 22, 2021
Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70. The U.S. has...
Via
Benzinga
Topics
Stocks
Mid-Morning Market Update: Markets Mostly Lower; AT&T Beats Q2 Estimates
↗
July 22, 2021
Following the market opening Thursday, the Dow traded down 0.24% to 34,715.42 while the NASDAQ rose 0.13% to 14,651.19. The S&P also fell, dropping 0.08% to 4,355.29. The U.S...
Via
Benzinga
Topics
Stocks
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
